Eric Horlick
Overview
Explore the profile of Eric Horlick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
1436
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Talla M, Best N, Challa A, Balakumar S, Lopez-Tejero S, Huszti E, et al.
Can J Cardiol
. 2025 Feb;
PMID: 39952466
Background: While Fontan palliation improves survival, it poses a large burden of lifelong morbidity. In extracardiac Fontan (ECF) patients, for example, conduit stenosis developed over time has been associated with...
2.
Lopez-Tejero S, Benson L, Horlick E, Osten M
Catheter Cardiovasc Interv
. 2025 Jan;
PMID: 39887642
We present an 18-year-old male with Fallot's tetralogy (ToF) repaired with a transannular and main pulmonary artery (PA) patch, who suffered an acute coronary artery compression after a Harmony-TPV deployment....
3.
Cepas-Guillen P, Flores-Umanzor E, Horlick E, Aboulhosn J, Benson L, Freixa X, et al.
Nat Rev Cardiol
. 2025 Jan;
PMID: 39833478
Advances in imaging diagnostics, surgical techniques and transcatheter interventions for paediatric patients with severe congenital heart disease (CHD) have substantially reduced mortality, thereby extending the lifespan of these individuals and...
4.
Flores-Umanzor E, Luna-Lopez R, Cepas-Guillen P, Montserrat S, Alshehri B, Keshvara R, et al.
Circ Cardiovasc Interv
. 2024 Nov;
17(12):e014699.
PMID: 39584255
The Fontan circuit is associated with chronically elevated systemic venous pressures and decreased cardiac output, often leading to circuit failure. Managing Fontan circuit failure is complex and requires multiple therapeutic...
5.
Lopez-Tejero S, Osten M, Chan Wah Hak Y, Challa A, Nguyen E, Horlick E
JACC Cardiovasc Interv
. 2024 Nov;
18(2):268-270.
PMID: 39570228
No abstract available.
6.
Flores-Umanzor E, Abrahamyan L, Asghar A, Schrutka L, Everett K, Lee D, et al.
Circ Cardiovasc Interv
. 2024 Nov;
17(11):e014467.
PMID: 39561239
Background: Evidence from trials suggests that patent foramen ovale closure is superior to medical therapy alone in reducing stroke recurrence in men but not in women. Evidence from real-world data...
7.
Farjat-Pasos J, Guedeney P, Horlick E, Abtan J, Nombela-Franco L, Hibbert B, et al.
EuroIntervention
. 2024 Aug;
20(16):1029-1038.
PMID: 39155753
Background: Limited data are available on transcatheter patent foramen ovale (PFO) closure outcomes in the elderly. Aims: Through this study, we aimed to determine the incidence and predictors of adverse...
8.
Tan W, Stefanescu Schmidt A, Horlick E, Aboulhosn J
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
1(6):100438.
PMID: 39132367
Patients with congenital heart disease now live well into adulthood because of advances in surgical techniques, improvements in medical management, and the development of novel therapeutic agents. As patients grow...
9.
Aboulhosn J, Pedra C, Horlick E, Akagi T, Chessa M
Eur Heart J
. 2024 Aug;
PMID: 39115082
No abstract available.
10.
Flores-Umanzor E, Alshehri B, Keshvara R, Wilson W, Osten M, Benson L, et al.
JACC Cardiovasc Interv
. 2024 May;
17(9):1079-1090.
PMID: 38749587
Tetralogy of Fallot (TOF) is the most common form of cyanotic congenital heart disease. Palliative procedures, either surgical or transcatheter, aim to improve oxygen saturation, affording definitive procedures at a...